Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

LUKE Named to 10-Year $43B Defense Health Agency IDIQ for the Medical Q-Coded Support and Services-Next Generation Program

Read more ››
By: GlobeNewswire - 03 May 2024

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets

Read more ››
By: PR Newswire Association LLC. - 03 May 2024
Related companies:  Nektar Therapeutics Inc.

Alleva Showcases Data-Driven EMR Platform at TCIV East 2024 Conference

Read more ››
By: PR Newswire Association LLC. - 03 May 2024

May is International 5p- Syndrome (Cri du Chat) Syndrome Awareness Month

Read more ››
By: PR Newswire Association LLC. - 03 May 2024

Goodness Growth Holdings Announces Filing of Application for Summary Determination in Litigation with Verano

Read more ››
By: GlobeNewswire - 02 May 2024

Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Ultragenyx Pharmaceutical Inc.

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Cytokinetics, Inc.

aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  aTyr Pharma Inc. | Lifecare AS | Pharmsynthez

Galapagos reports first quarter 2024 financial results  

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Galapagos NV

Ascendis Pharma Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Ascendis Pharma A/S

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Xenon Pharmaceuticals Inc.

Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Monte Rosa Therapeutics, Inc.

Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Vor BioPharma, Inc.

WW International, Inc. Announces First Quarter 2024 Results

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  WW International, Inc.

Mustang Bio Announces Closing of $4 Million Public Offering

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  MindBio Therapeutics Corp

Soleno Therapeutics Announces Proposed Public Offering of Common Stock

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Soleno Therapeutics, Inc.

Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Corvus Pharmaceuticals, Inc.

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Ardelyx, Inc

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Zymeworks Inc.

Codexis Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Codexis, Inc.
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »